JF
OLMA icon

Jump Financial’s Olema Pharmaceuticals OLMA Stock Holding History

Jump Financial’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.75M Buy
452,966
+352,692
+352% +$7.85M 0.09% 260
2025
Q4 		$2.51M Buy
+100,274
New +$1.78M 0.03% 595
2024
Q4 		– Sell
-63,041
Closed -$753K – 1900
2024
Q3 		$753K Buy
63,041
+32,449
+106% +$415K 0.02% 928
2024
Q2 		$331K Buy
+30,592
New +$332K 0.01% 1336
2024
Q1 		– Sell
-19,866
Closed -$279K – 2181
2023
Q4 		$279K Buy
+19,866
New +$267K 0.01% 1383
2022
Q3 		– Sell
-30,533
Closed -$124K – 1843
2022
Q2 		$124K Sell
30,533
-7,967
-21% -$25.3K 0.01% 1410
2022
Q1 		$164K Buy
38,500
+24,338
+172% +$134K 0.01% 1348
2021
Q4 		$133K Buy
+14,162
New +$293K 0.01% 1186

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Jump Financial's OLMA Position: Q1 2026 in Review

Jump Financial increased its Olema Pharmaceuticals (OLMA) stake by 352% in Q1 2026, buying an estimated $7.85M and bringing the position to 452,966 shares worth $6.75M. The position accounts for 0.09% of the portfolio, ranked #260.

Jump Financial first reported a position in OLMA in Q4 2021 and has held it in 8 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Jump Financial held 452,966 shares of Olema Pharmaceuticals worth $6.75M as of Q1 2026.
  • Jump Financial bought 352,692 Olema Pharmaceuticals shares in Q1 2026, an estimated $7.85M.
  • Olema Pharmaceuticals made up 0.09% of Jump Financial's portfolio in Q1 2026, its #260 holding.
  • Jump Financial first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 8 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.